VCM
EXAS

Versant Capital Management’s Exact Sciences EXAS Stock Holding History

Versant Capital Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,205
Closed -$122K – 2810
2025
Q4 		$122K Buy
1,205
+9
+0.8% +$723 0.02% 664
2025
Q3 		$65.4K Buy
1,196
+1,027
+608% +$51.3K 0.01% 904
2025
Q2 		$8.98K Buy
169
+48
+40% +$2.44K ﹤0.01% 1932
2025
Q1 		$5.24K Buy
121
+36
+42% +$1.82K ﹤0.01% 2014
2024
Q4 		$4.78K Buy
85
+53
+166% +$3.3K ﹤0.01% 1782
2024
Q3 		$2.18K Sell
32
-6
-16% -$339 ﹤0.01% 1539
2024
Q2 		$1.61K Buy
+38
New +$2.09K ﹤0.01% 1557
2024
Q1 		– Sell
-14
Closed -$1.04K – 1900
2023
Q4 		$1.04K Sell
14
-6
-30% -$393 ﹤0.01% 1497
2023
Q3 		$1.36K Hold
20
– – ﹤0.01% 1437
2023
Q2 		$1.88K Buy
+20
New +$1.56K ﹤0.01% 1394
2020
Q1 		– Sell
-4
Closed – – 1410
2019
Q4 		$0 Buy
+4
New +$352 ﹤0.01% 1417

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.46B AUM 22.77% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Versant Capital Management's EXAS Position: Q1 2026 in Review

Versant Capital Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 1,205 shares — an estimated $122K sold.

Versant Capital Management first reported a position in EXAS in Q4 2019 and held it in 11 quarters. The position peaked at $122K in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Versant Capital Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Versant Capital Management sold 1,205 Exact Sciences shares in Q1 2026, an estimated $122K.
  • Versant Capital Management first reported a position in Exact Sciences in Q4 2019 and held it in 11 quarters.
  • Versant Capital Management's Exact Sciences position peaked at $122K in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Versant Capital Management's 13F filing for Q1 2026, filed 7 Apr 2026.